spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

T3: Trials, Tech and Transformation

T3_2018

30-31 May 2018
Raleigh Convention Center, Raleigh, NC

T3 is back for 2018 to provide you with the latest updates and top tips from across the clinical trials landscape. Connecting leading experts, influencers and innovators from pharma, biotech, CROs, patient advocacy groups, academia and beyond, T3 is themeeting place for all stakeholders to voice their questions, connect with peers, and get direct feedback from an expert speaker line-up. And this year, we're in Raleigh.

Explore:

• Paradigm Shifts in Clinical Trials: Partnerships and Collaboration, Digital Transformation, New Technology and Innovation, and The Changing Landscape

• Patients as Partners: Voice of the Patient, Recruitment and Engagement

• Clinical Research: Real-Time Data and Analytics

• Insights and Innovations from Immuno-oncology and Rare Disease

Book now to secure your place alongside leading clinical professionals on 30-31 May, ask your questions, and put yourself at the heart of the latest clinical discussions.

Download the agenda to see what we have lined up for you: https://goo.gl/cMq9qC

Visit the website to find out more: www.t3clinicalevent.com

 

phone 1 941-554-3500
email register@knect365.com
web goo.gl/VucvDb
email Raleigh Convention Center, NC
 
Print this page
Send to a friend
   
spacer
Industry Events

SAPHEX 2019

23-24 October 2019, GALLAGHER CONVENTION CENTRE, 10 RICHARDS DRIVE, HALFWAY HOUSE, MIDRAND, 1685, SOUTH AFRICA

SAPHEX 2019 will be held on the 23rd-24th October at the Gallagher Convention Centre, Johannesburg, South Africa.
More info >>

White Papers

Trial Timelines

Thomson Reuters

Save resources with accurate trial length projections. How analytics based on curated content can deliver insight for clinical strategies.
More info >>


News and Press Releases

MedPharm announce expansion of partnership with Palvella Therapeutics in developing a new treatment for the debilitating rare disease, pachyonychia congenita

MedPharm Ltd have announced the expansion of their partnership with Palvella Therapeutics, Inc., a Philadelphia-based biopharmaceutical company focused on developing and commercialising therapies for debilitating, rare genetic diseases. To date, MedPharm has employed its world-renowned specialist formulation expertise to support Palvella’s development of a novel, high-strength rapamycin topical formulation for application to the skin (PTX 022) as a disease-modifying treatment for pachyonychia congenita (PC). Most recently, MedPharm has made arrangements to manufacture the clinical (IMP) batches for use in Palvella’s upcoming Phase 2/3 clinical study.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement